Salarius Pharmaceuticals, Inc.Salarius Pharmaceuticals, Inc.Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪2.14 M‬USD
−4.5386USD
‪−12.54 M‬USD
‪4.02 M‬
Beta (1Y)
−0.64

About Salarius Pharmaceuticals, Inc.

CEO
David J. Arthur
Headquarters
Houston
Employees (FY)
2
Founded
2014
ISIN
US79400X3052
FIGI
BBG00740LLD5
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SLRX is 0.50 USD — it has increased by 0.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Salarius Pharmaceuticals, Inc. stocks are traded under the ticker SLRX.
Salarius Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Salarius Pharmaceuticals, Inc. has a max estimate of 3.25 USD and a min estimate of 3.25 USD.
SLRX earnings for the last quarter are −1.43 USD whereas the estimation was −1.30 USD which accounts for −10.28% surprise. Estimated earnings for the next quarter are −0.67 USD. See more details about Salarius Pharmaceuticals, Inc. earnings.
Salarius Pharmaceuticals, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪1.16 M‬ USD. In the next quarter revenue is expected to reach ‪325.00 K‬ USD.
Yes, you can track Salarius Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, SLRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Salarius Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
SLRX reached its all-time high on Apr 22, 2015 with the price of 15512.50 USD, and its all-time low was 0.43 USD and was reached on Apr 2, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 2.00 employees. See our rating of the largest employees — is Salarius Pharmaceuticals, Inc. on this list?